Exploratory Data Analysis
Of those who became DISABLEd post vaccination, which symptoms did they have?
Field Analysis:
First see
Normalized Table AD_2019_ALL_SYMP_NORM
—
Query:
select asn.Symptom,
count(*) Count
from dbo.[AD_2019_ALL_SYMP_NORM] asn
join dbo.[VAERSDATA] VD
on ASN.VAERS_ID = VD.VAERS_ID
where DISABLE IS NOT NULl
group by asn.symptom
order by 2 desc, 1
—
Results:
| Symptom | Count | Percent Weight | Percent Running Total |
|---|---|---|---|
| Pyrexia (fever) | 2,403 | 1.946 | 1.946 |
| Pain | 2,246 | 1.819 | 3.765 |
| Fatigue | 2,193 | 1.776 | 5.542 |
| Headache | 2,090 | 1.693 | 7.234 |
| Arthralgia (joint pain) | 2,011 | 1.629 | 8.863 |
| Asthenia (weakness) | 1,740 | 1.409 | 10.272 |
| Myalgia (muscle pain) | 1,396 | 1.131 | 11.403 |
| Pain in extremity | 1,334 | 1.08 | 12.483 |
| Dizziness | 1,327 | 1.075 | 13.558 |
| Paraesthesia (abnormal skin sensation) | 1,169 | 0.947 | 14.505 |
| Muscular weakness | 1,076 | 0.871 | 15.377 |
| Hypoaesthesia (numbness) | 1,048 | 0.849 | 16.225 |
| Nausea | 1,036 | 0.839 | 17.064 |
| Injection site pain | 996 | 0.807 | 17.871 |
| Malaise (general discomfort) | 925 | 0.749 | 18.62 |
| Autism | 873 | 0.707 | 19.327 |
| Rash | 863 | 0.699 | 20.026 |
| Convulsion | 858 | 0.695 | 20.721 |
| Gait disturbance | 857 | 0.694 | 21.415 |
| Dyspnoea (Shortness of breath) | 772 | 0.625 | 22.041 |
| Vomiting | 754 | 0.611 | 22.651 |
| Laboratory test abnormal | 745 | 0.603 | 23.255 |
| Diarrhoea | 741 | 0.6 | 23.855 |
| Activities of daily living impaired | 722 | 0.585 | 24.44 |
| Back pain | 675 | 0.547 | 24.986 |
| Blood test | 631 | 0.511 | 25.498 |
| Herpes zoster | 624 | 0.505 | 26.003 |
| Guillain-Barre syndrome | 594 | 0.481 | 26.484 |
| Abdominal pain | 585 | 0.474 | 26.958 |
| Insomnia | 572 | 0.463 | 27.421 |
| Speech disorder | 562 | 0.455 | 27.876 |
| Nuclear magnetic resonance imaging | 561 | 0.454 | 28.331 |
| Hypokinesia (decreased bodily movement) | 559 | 0.453 | 28.783 |
| Condition aggravated | 541 | 0.438 | 29.222 |
| Mobility decreased | 500 | 0.405 | 29.627 |
| Paralysis | 491 | 0.398 | 30.024 |
| Crying | 482 | 0.39 | 30.415 |
| Disturbance in attention | 467 | 0.378 | 30.793 |
| Injected limb mobility decreased | 460 | 0.373 | 31.165 |
| Syncope (fainting) | 441 | 0.357 | 31.523 |
| Arthritis | 435 | 0.352 | 31.875 |
| Depression | 432 | 0.35 | 32.225 |
| Laboratory test | 427 | 0.346 | 32.571 |
| Aphasia | 420 | 0.34 | 32.911 |
| Muscle spasms | 420 | 0.34 | 33.251 |
| Loss of personal independence in daily activities | 416 | 0.337 | 33.588 |
| Musculoskeletal pain | 416 | 0.337 | 33.925 |
| Chills | 411 | 0.333 | 34.258 |
| Multiple sclerosis | 406 | 0.329 | 34.587 |
| Cognitive disorder | 402 | 0.326 | 34.912 |
| Abnormal behaviour | 401 | 0.325 | 35.237 |
| Erythema | 400 | 0.324 | 35.561 |
| Infection | 397 | 0.322 | 35.882 |
| Anxiety | 392 | 0.317 | 36.2 |
| Sleep disorder | 392 | 0.317 | 36.517 |
| Neck pain | 391 | 0.317 | 36.834 |
| Balance disorder | 383 | 0.31 | 37.144 |
| Chest pain | 382 | 0.309 | 37.454 |
| Injection site erythema | 379 | 0.307 | 37.761 |
| Somnolence | 373 | 0.302 | 38.063 |
| Tremor | 373 | 0.302 | 38.365 |
| Disability | 371 | 0.3 | 38.665 |
| Influenza like illness | 370 | 0.3 | 38.965 |
| Injection site swelling | 360 | 0.292 | 39.257 |
| Neuropathy | 355 | 0.288 | 39.544 |
| Cough | 354 | 0.287 | 39.831 |
| Musculoskeletal stiffness | 354 | 0.287 | 40.118 |
| Nervous system disorder | 348 | 0.282 | 40.399 |
| Hypotonia | 346 | 0.28 | 40.68 |
| Abasia | 336 | 0.272 | 40.952 |
| Lethargy | 333 | 0.27 | 41.222 |
| Oedema peripheral | 333 | 0.27 | 41.491 |
| Impaired work ability | 322 | 0.261 | 41.752 |
| Decreased appetite | 320 | 0.259 | 42.011 |
| Memory impairment | 312 | 0.253 | 42.264 |
| Dyskinesia | 306 | 0.248 | 42.512 |
| Computerised tomogram | 305 | 0.247 | 42.759 |
| Lumbar puncture | 300 | 0.243 | 43.002 |
| Amnesia | 299 | 0.242 | 43.244 |
| Weight decreased | 289 | 0.234 | 43.478 |
| Immediate post-injection reaction | 287 | 0.232 | 43.71 |
| Mental retardation severity unspecified | 287 | 0.232 | 43.943 |
| Autism spectrum disorder | 278 | 0.225 | 44.168 |
| Constipation | 277 | 0.224 | 44.392 |
| Electroencephalogram abnormal | 275 | 0.223 | 44.615 |
| Feeling abnormal | 275 | 0.223 | 44.838 |
| Abdominal pain upper | 272 | 0.22 | 45.058 |
| Migraine | 272 | 0.22 | 45.278 |
| Hypersensitivity | 271 | 0.219 | 45.498 |
| Blood test normal | 265 | 0.215 | 45.713 |
| Pruritus | 265 | 0.215 | 45.927 |
| Neuralgia | 264 | 0.214 | 46.141 |
| Nuclear magnetic resonance imaging abnormal | 264 | 0.214 | 46.355 |
| Nuclear magnetic resonance imaging normal | 261 | 0.211 | 46.566 |
| Screaming | 260 | 0.211 | 46.777 |
| Seizure | 258 | 0.209 | 46.986 |
| Gastrointestinal disorder | 257 | 0.208 | 47.194 |
| Irritability | 254 | 0.206 | 47.4 |
| Joint swelling | 254 | 0.206 | 47.605 |
| Vertigo | 254 | 0.206 | 47.811 |
| Hyperhidrosis | 253 | 0.205 | 48.016 |
| Palpitations | 253 | 0.205 | 48.221 |
| Coordination abnormal | 251 | 0.203 | 48.424 |
| Loss of consciousness | 249 | 0.202 | 48.626 |
| Deafness | 244 | 0.198 | 48.824 |
| Immune system disorder | 244 | 0.198 | 49.021 |
| Fall | 241 | 0.195 | 49.216 |
| Vision blurred | 240 | 0.194 | 49.411 |
| Rheumatoid arthritis | 239 | 0.194 | 49.604 |
| Encephalitis | 238 | 0.193 | 49.797 |
| Agitation | 232 | 0.188 | 49.985 |
| Lymphadenopathy | 232 | 0.188 | 50.173 |
| Sensory disturbance | 230 | 0.186 | 50.359 |
| Tinnitus | 229 | 0.185 | 50.545 |
| Visual impairment | 227 | 0.184 | 50.729 |
| Dysphagia | 224 | 0.181 | 50.91 |
| Laboratory test normal | 224 | 0.181 | 51.091 |
| Blindness | 223 | 0.181 | 51.272 |
| Fibromyalgia | 216 | 0.175 | 51.447 |
| Myofascitis | 215 | 0.174 | 51.621 |
| Photophobia | 215 | 0.174 | 51.795 |
| Swelling | 214 | 0.173 | 51.969 |
| Developmental delay | 210 | 0.17 | 52.139 |
| Visual disturbance | 210 | 0.17 | 52.309 |
| Neurodevelopmental disorder | 208 | 0.168 | 52.477 |
| Confusional state | 207 | 0.168 | 52.645 |
| Injection site reaction | 207 | 0.168 | 52.812 |
| Urticaria | 207 | 0.168 | 52.98 |
| Burning sensation | 206 | 0.167 | 53.147 |
| Muscle twitching | 206 | 0.167 | 53.314 |
| Myasthenic syndrome | 201 | 0.163 | 53.477 |
| X-ray | 199 | 0.161 | 53.638 |
| Encephalopathy | 197 | 0.16 | 53.797 |
| Immunoglobulin therapy | 196 | 0.159 | 53.956 |
| Alopecia | 195 | 0.158 | 54.114 |
| Nuclear magnetic resonance imaging brain abnormal | 194 | 0.157 | 54.271 |
| Pneumonia | 194 | 0.157 | 54.428 |
| Influenza | 190 | 0.154 | 54.582 |
| Dysstasia | 187 | 0.151 | 54.734 |
| Wheelchair user | 185 | 0.15 | 54.883 |
| Postural orthostatic tachycardia syndrome | 184 | 0.149 | 55.033 |
| CSF test abnormal | 182 | 0.147 | 55.18 |
| Epilepsy | 180 | 0.146 | 55.326 |
| Hypertension | 176 | 0.143 | 55.468 |
| Optic neuritis | 175 | 0.142 | 55.61 |
| Demyelination | 170 | 0.138 | 55.748 |
| Difficulty in walking | 169 | 0.137 | 55.885 |
| Computerised tomogram normal | 168 | 0.136 | 56.021 |
| Inflammation | 167 | 0.135 | 56.156 |
| Muscle atrophy | 167 | 0.135 | 56.291 |
| Speech disorder developmental | 166 | 0.134 | 56.426 |
| Viral infection | 164 | 0.133 | 56.558 |
| Electroencephalogram | 163 | 0.132 | 56.69 |
| Asthma | 162 | 0.131 | 56.822 |
| Decreased eye contact | 158 | 0.128 | 56.95 |
| Body temperature increased | 157 | 0.127 | 57.077 |
| Chronic fatigue syndrome | 156 | 0.126 | 57.203 |
| Nuclear magnetic resonance imaging brain normal | 156 | 0.126 | 57.329 |
| Peripheral swelling | 156 | 0.126 | 57.456 |
| Arthropathy | 154 | 0.125 | 57.581 |
| Electromyogram abnormal | 154 | 0.125 | 57.705 |
| Anorexia | 152 | 0.123 | 57.828 |
| Diplopia | 152 | 0.123 | 57.952 |
| Injection site oedema | 152 | 0.123 | 58.075 |
| Myelitis transverse | 152 | 0.123 | 58.198 |
| Diabetes mellitus | 150 | 0.121 | 58.319 |
| Hypersomnia | 150 | 0.121 | 58.441 |
| Joint range of motion decreased | 150 | 0.121 | 58.562 |
| Oropharyngeal pain | 149 | 0.121 | 58.683 |
| Red blood cell sedimentation rate increased | 146 | 0.118 | 58.801 |
| Fasciitis | 145 | 0.117 | 58.919 |
| Eye pain | 144 | 0.117 | 59.035 |
| Intensive care | 144 | 0.117 | 59.152 |
| Autoimmune disorder | 143 | 0.116 | 59.268 |
| Cerebrovascular accident | 143 | 0.116 | 59.383 |
| Eye disorder | 143 | 0.116 | 59.499 |
| Injection site warmth | 141 | 0.114 | 59.613 |
| Joint stiffness | 139 | 0.113 | 59.726 |
| Staring | 139 | 0.113 | 59.839 |
| Discomfort | 138 | 0.112 | 59.95 |
| Drug toxicity | 138 | 0.112 | 60.062 |
| Heart rate increased | 138 | 0.112 | 60.174 |
| Neuropathy peripheral | 137 | 0.111 | 60.285 |
| Pallor | 137 | 0.111 | 60.396 |
| Hypertonia | 136 | 0.11 | 60.506 |
| Hyperacusis | 135 | 0.109 | 60.615 |
| Dysuria | 134 | 0.109 | 60.724 |
| Blister | 133 | 0.108 | 60.832 |
| Gait inability | 132 | 0.107 | 60.939 |
| Facial palsy | 131 | 0.106 | 61.045 |
| Walking aid user | 131 | 0.106 | 61.151 |
| Dysarthria | 130 | 0.105 | 61.256 |
| Movement disorder | 129 | 0.104 | 61.361 |
| Myelitis | 128 | 0.104 | 61.464 |
| Motor dysfunction | 127 | 0.103 | 61.567 |
| Oedema | 127 | 0.103 | 61.67 |
| Electrocardiogram | 125 | 0.101 | 61.771 |
| Vaccination complication | 125 | 0.101 | 61.872 |
| Hemiparesis | 124 | 0.1 | 61.973 |
| Quality of life decreased | 124 | 0.1 | 62.073 |
| C-reactive protein increased | 122 | 0.099 | 62.172 |
| Emotional distress | 122 | 0.099 | 62.271 |
| Ear pain | 120 | 0.097 | 62.368 |
| Full blood count | 120 | 0.097 | 62.465 |
| Social avoidant behaviour | 120 | 0.097 | 62.562 |
| Unresponsive to stimuli | 120 | 0.097 | 62.66 |
| Aggression | 119 | 0.096 | 62.756 |
| Feeling hot | 119 | 0.096 | 62.852 |
| Grand mal convulsion | 119 | 0.096 | 62.949 |
| Cyanosis | 118 | 0.096 | 63.044 |
| Sensory loss | 118 | 0.096 | 63.14 |
| Antinuclear antibody positive | 117 | 0.095 | 63.235 |
| Apnoea | 117 | 0.095 | 63.329 |
| Electroencephalogram normal | 117 | 0.095 | 63.424 |
| Electromyogram | 117 | 0.095 | 63.519 |
| Stupor | 117 | 0.095 | 63.614 |
| Tachycardia | 117 | 0.095 | 63.709 |
| Cellulitis | 115 | 0.093 | 63.802 |
| Full blood count normal | 115 | 0.093 | 63.895 |
| Osteoarthritis | 115 | 0.093 | 63.988 |
| Coma | 114 | 0.092 | 64.08 |
| Pharyngitis | 114 | 0.092 | 64.173 |
| Anaemia | 113 | 0.092 | 64.264 |
| Dehydration | 113 | 0.092 | 64.356 |
| Drug ineffective | 113 | 0.092 | 64.447 |
| Nerve injury | 113 | 0.092 | 64.539 |
| Nuclear magnetic resonance imaging brain | 113 | 0.092 | 64.63 |
| Eczema | 111 | 0.09 | 64.72 |
| Bedridden | 108 | 0.087 | 64.808 |
| Deafness unilateral | 108 | 0.087 | 64.895 |
| Hypotension | 108 | 0.087 | 64.983 |
| Tenderness | 108 | 0.087 | 65.07 |
| Abdominal distension | 106 | 0.086 | 65.156 |
| Neurological symptom | 106 | 0.086 | 65.242 |
| Systemic lupus erythematosus | 106 | 0.086 | 65.328 |
| Blood glucose increased | 104 | 0.084 | 65.412 |
| Presyncope | 104 | 0.084 | 65.496 |
| Vaccination failure | 104 | 0.084 | 65.58 |
| Hypoacusis | 103 | 0.083 | 65.664 |
| Skin lesion | 103 | 0.083 | 65.747 |
| General physical health deterioration | 101 | 0.082 | 65.829 |
| Injury | 101 | 0.082 | 65.911 |
| Muscle disorder | 101 | 0.082 | 65.993 |
| Nasopharyngitis | 101 | 0.082 | 66.074 |
| Surgery | 99 | 0.08 | 66.155 |
| Biopsy muscle abnormal | 98 | 0.079 | 66.234 |
| Death | 98 | 0.079 | 66.313 |
| Blood creatine phosphokinase increased | 97 | 0.079 | 66.392 |
| Skin disorder | 97 | 0.079 | 66.47 |
| Thinking abnormal | 97 | 0.079 | 66.549 |
| Chest discomfort | 96 | 0.078 | 66.627 |
| Type 1 diabetes mellitus | 96 | 0.078 | 66.704 |
| Injection site mass | 95 | 0.077 | 66.781 |
| Bone pain | 94 | 0.076 | 66.858 |
| Contusion | 94 | 0.076 | 66.934 |
| Otitis media | 94 | 0.076 | 67.01 |
| Psychomotor hyperactivity | 94 | 0.076 | 67.086 |
| Urinary incontinence | 94 | 0.076 | 67.162 |
| Antinuclear antibody | 93 | 0.075 | 67.237 |
| Injection site induration | 92 | 0.075 | 67.312 |
| Urine analysis | 91 | 0.074 | 67.386 |
| Visual acuity reduced | 91 | 0.074 | 67.459 |
| Antinuclear antibody negative | 90 | 0.073 | 67.532 |
| Dyspepsia | 90 | 0.073 | 67.605 |
| Hyperaesthesia | 90 | 0.073 | 67.678 |
| Abdominal discomfort | 89 | 0.072 | 67.75 |
| Blood test abnormal | 89 | 0.072 | 67.822 |
| Borrelia test negative | 89 | 0.072 | 67.894 |
| Dry eye | 89 | 0.072 | 67.966 |
| Feeling cold | 89 | 0.072 | 68.038 |
| Limb discomfort | 89 | 0.072 | 68.111 |
| Personality disorder | 89 | 0.072 | 68.183 |
| Rash generalised | 88 | 0.071 | 68.254 |
| Antisocial behaviour | 87 | 0.07 | 68.324 |
| Autonomic nervous system imbalance | 87 | 0.07 | 68.395 |
| Post herpetic neuralgia | 87 | 0.07 | 68.465 |
| Respiratory disorder | 87 | 0.07 | 68.536 |
| Lumbar puncture normal | 86 | 0.07 | 68.605 |
| Musculoskeletal disorder | 86 | 0.07 | 68.675 |
| Delirium | 85 | 0.069 | 68.744 |
| Ataxia | 84 | 0.068 | 68.812 |
| Depressed level of consciousness | 84 | 0.068 | 68.88 |
| Febrile convulsion | 84 | 0.068 | 68.948 |
| Meningitis | 84 | 0.068 | 69.016 |
| Regressive behaviour | 84 | 0.068 | 69.084 |
| Alanine aminotransferase increased | 83 | 0.067 | 69.151 |
| C-reactive protein normal | 83 | 0.067 | 69.218 |
| CSF protein increased | 83 | 0.067 | 69.286 |
| Skin warm | 83 | 0.067 | 69.353 |
| Computerised tomogram head | 82 | 0.066 | 69.419 |
| Electromyogram normal | 82 | 0.066 | 69.486 |
| Eye movement disorder | 81 | 0.066 | 69.551 |
| Gastrooesophageal reflux disease | 81 | 0.066 | 69.617 |
| Inappropriate schedule of drug administration | 81 | 0.066 | 69.683 |
| Metal poisoning | 81 | 0.066 | 69.748 |
| White blood cell count increased | 81 | 0.066 | 69.814 |
| Bronchitis | 80 | 0.065 | 69.879 |
| Dry mouth | 80 | 0.065 | 69.943 |
| Rash vesicular | 80 | 0.065 | 70.008 |
| Chest X-ray | 79 | 0.064 | 70.072 |
| Dysphonia | 79 | 0.064 | 70.136 |
| Facial paralysis | 79 | 0.064 | 70.2 |
| Orthostatic intolerance | 79 | 0.064 | 70.264 |
| Rash erythematous | 79 | 0.064 | 70.328 |
| Sinusitis | 79 | 0.064 | 70.392 |
| Ultrasound scan | 79 | 0.064 | 70.456 |
| Vaccine positive rechallenge | 79 | 0.064 | 70.52 |
| Complex regional pain syndrome | 78 | 0.063 | 70.583 |
| Lumbar puncture abnormal | 78 | 0.063 | 70.646 |
| Grip strength decreased | 77 | 0.062 | 70.709 |
| Skin discolouration | 77 | 0.062 | 70.771 |
| Rhinorrhoea | 76 | 0.062 | 70.833 |
| Skin ulcer | 76 | 0.062 | 70.894 |
| Bursitis | 75 | 0.061 | 70.955 |
| Computerised tomogram abnormal | 75 | 0.061 | 71.016 |
| Food allergy | 75 | 0.061 | 71.076 |
| Post viral fatigue syndrome | 75 | 0.061 | 71.137 |
| Strabismus | 75 | 0.061 | 71.198 |
| Disorientation | 74 | 0.06 | 71.258 |
| Impaired driving ability | 74 | 0.06 | 71.318 |
| Unevaluable event | 74 | 0.06 | 71.378 |
| Aspartate aminotransferase increased | 73 | 0.059 | 71.437 |
| Chest X-ray normal | 73 | 0.059 | 71.496 |
| Electrocardiogram normal | 73 | 0.059 | 71.555 |
| Hyperventilation | 73 | 0.059 | 71.614 |
| Pollakiuria | 73 | 0.059 | 71.673 |
| Blood glucose normal | 72 | 0.058 | 71.732 |
| Brain injury | 72 | 0.058 | 71.79 |
| Infantile spasms | 72 | 0.058 | 71.848 |
| Ear infection | 71 | 0.058 | 71.906 |
| Hearing impaired | 71 | 0.058 | 71.963 |
| Hemiplegia | 71 | 0.058 | 72.021 |
| Monoplegia | 71 | 0.058 | 72.078 |
| Narcolepsy | 71 | 0.058 | 72.136 |
| Peripheral coldness | 71 | 0.058 | 72.193 |
| Fibrosis tendinous | 70 | 0.057 | 72.25 |
| Mental impairment | 70 | 0.057 | 72.307 |
| Tic | 70 | 0.057 | 72.363 |
| Night sweats | 69 | 0.056 | 72.419 |
| Childhood disintegrative disorder | 68 | 0.055 | 72.474 |
| Neuritis | 68 | 0.055 | 72.53 |
| Periarthritis | 68 | 0.055 | 72.585 |
| Echocardiogram | 67 | 0.054 | 72.639 |
| Areflexia | 66 | 0.053 | 72.692 |
| Hair metal test abnormal | 66 | 0.053 | 72.746 |
| Menstruation irregular | 66 | 0.053 | 72.799 |
| Nerve conduction studies | 66 | 0.053 | 72.853 |
| Rhinitis | 66 | 0.053 | 72.906 |
| CSF test normal | 65 | 0.053 | 72.959 |
| Injection site hypersensitivity | 65 | 0.053 | 73.011 |
| Myositis | 65 | 0.053 | 73.064 |
| Thirst | 65 | 0.053 | 73.117 |
| Vasculitis | 65 | 0.053 | 73.169 |
| Wheezing | 65 | 0.053 | 73.222 |
| Bone disorder | 64 | 0.052 | 73.274 |
| Metabolic function test | 64 | 0.052 | 73.326 |
| Neurological examination | 64 | 0.052 | 73.378 |
| Dysmenorrhoea | 63 | 0.051 | 73.429 |
| Epistaxis | 63 | 0.051 | 73.48 |
| Haematochezia | 63 | 0.051 | 73.531 |
| Neurological examination abnormal | 63 | 0.051 | 73.582 |
| Sepsis | 63 | 0.051 | 73.633 |
| Bacterial infection | 62 | 0.05 | 73.683 |
| Hyporeflexia | 62 | 0.05 | 73.733 |
| Tilt table test positive | 62 | 0.05 | 73.783 |
| Attention deficit/hyperactivity disorder | 61 | 0.049 | 73.833 |
| Deafness neurosensory | 61 | 0.049 | 73.882 |
| Hallucination | 61 | 0.049 | 73.931 |
| Menstrual disorder | 61 | 0.049 | 73.981 |
| Visual field defect | 61 | 0.049 | 74.03 |
| Amenorrhoea | 60 | 0.049 | 74.079 |
| Hypothyroidism | 60 | 0.049 | 74.127 |
| Dementia | 59 | 0.048 | 74.175 |
| Hypoxia | 59 | 0.048 | 74.223 |
| Nasal congestion | 59 | 0.048 | 74.271 |
| Neurological examination normal | 59 | 0.048 | 74.319 |
| Chronic inflammatory demyelinating polyradiculoneuropathy | 58 | 0.047 | 74.366 |
| Mechanical ventilation | 58 | 0.047 | 74.413 |
| Upper respiratory tract infection | 58 | 0.047 | 74.46 |
| Central nervous system lesion | 57 | 0.046 | 74.506 |
| Cerebellar syndrome | 57 | 0.046 | 74.552 |
| Diplegia | 57 | 0.046 | 74.598 |
| Eating disorder | 57 | 0.046 | 74.644 |
| Endotracheal intubation | 57 | 0.046 | 74.69 |
| Muscle contractions involuntary | 57 | 0.046 | 74.737 |
| Nervousness | 57 | 0.046 | 74.783 |
| Nuclear magnetic resonance imaging spinal abnormal | 57 | 0.046 | 74.829 |
| Polyarthritis | 57 | 0.046 | 74.875 |
| Blindness unilateral | 56 | 0.045 | 74.92 |
| Cold sweat | 56 | 0.045 | 74.966 |
| Injection site inflammation | 56 | 0.045 | 75.011 |
| Drug administered at inappropriate site | 55 | 0.045 | 75.056 |
| Mental disorder | 55 | 0.045 | 75.1 |
| Apathy | 54 | 0.044 | 75.144 |
| Gaze palsy | 54 | 0.044 | 75.188 |
| Nerve conduction studies abnormal | 54 | 0.044 | 75.231 |
| Weight increased | 54 | 0.044 | 75.275 |
| Acne | 53 | 0.043 | 75.318 |
| Acute disseminated encephalomyelitis | 53 | 0.043 | 75.361 |
| Amblyopia | 53 | 0.043 | 75.404 |
| Computerised tomogram head normal | 53 | 0.043 | 75.447 |
| Depressed mood | 53 | 0.043 | 75.49 |
| Hot flush | 53 | 0.043 | 75.533 |
| Nystagmus | 53 | 0.043 | 75.576 |
| Plasmapheresis | 53 | 0.043 | 75.619 |
| Myopathy | 52 | 0.042 | 75.661 |
| Rash maculo-papular | 52 | 0.042 | 75.703 |
| Tendonitis | 52 | 0.042 | 75.745 |
| Urinary tract infection | 52 | 0.042 | 75.787 |
| Weight bearing difficulty | 52 | 0.042 | 75.829 |
| Blood pressure increased | 51 | 0.041 | 75.87 |
| Conjunctivitis | 51 | 0.041 | 75.912 |
| Exercise tolerance decreased | 51 | 0.041 | 75.953 |
| Hyperglycaemia | 51 | 0.041 | 75.994 |
| Leukocytosis | 51 | 0.041 | 76.036 |
| Neuralgic amyotrophy | 51 | 0.041 | 76.077 |
| Radiculitis brachial | 51 | 0.041 | 76.118 |
| Allergy test | 50 | 0.04 | 76.159 |
| Generalised tonic-clonic seizure | 50 | 0.04 | 76.199 |
| Local swelling | 50 | 0.04 | 76.24 |
| Lung disorder | 50 | 0.04 | 76.28 |
| Oral intake reduced | 50 | 0.04 | 76.321 |
| X-ray normal | 50 | 0.04 | 76.361 |
| Anger | 49 | 0.04 | 76.401 |
| Arrhythmia | 49 | 0.04 | 76.441 |
| Blood thyroid stimulating hormone normal | 49 | 0.04 | 76.48 |
| Eyelid ptosis | 49 | 0.04 | 76.52 |
| Faecal incontinence | 49 | 0.04 | 76.56 |
| Incorrect route of drug administration | 49 | 0.04 | 76.599 |
| Irritable bowel syndrome | 49 | 0.04 | 76.639 |
| Paresis | 49 | 0.04 | 76.679 |
| Quadriplegia | 49 | 0.04 | 76.718 |
| Ultrasound scan normal | 49 | 0.04 | 76.758 |
| Blood creatinine normal | 48 | 0.039 | 76.797 |
| Dizziness postural | 48 | 0.039 | 76.836 |
| Eye swelling | 48 | 0.039 | 76.875 |
| Injection site rash | 48 | 0.039 | 76.914 |
| Intussusception | 48 | 0.039 | 76.953 |
| Local reaction | 48 | 0.039 | 76.991 |
| Physical disability | 48 | 0.039 | 77.03 |
| Stereotypy | 48 | 0.039 | 77.069 |
| Vaccination site pain | 48 | 0.039 | 77.108 |
| Blood count | 47 | 0.038 | 77.146 |
| Clumsiness | 47 | 0.038 | 77.184 |
| Decreased activity | 47 | 0.038 | 77.222 |
| Ear disorder | 47 | 0.038 | 77.26 |
| Feeding disorder | 47 | 0.038 | 77.298 |
| Myoclonus | 47 | 0.038 | 77.336 |
| Platelet count decreased | 47 | 0.038 | 77.375 |
| Poliomyelitis | 47 | 0.038 | 77.413 |
| Polyneuropathy | 47 | 0.038 | 77.451 |
| Posture abnormal | 47 | 0.038 | 77.489 |
| Anaphylactic reaction | 46 | 0.037 | 77.526 |
| Cataplexy | 46 | 0.037 | 77.563 |
| Flushing | 46 | 0.037 | 77.6 |
| Haemorrhage | 46 | 0.037 | 77.638 |
| Blood electrolytes normal | 45 | 0.036 | 77.674 |
| Brain oedema | 45 | 0.036 | 77.711 |
| Cardiac arrest | 45 | 0.036 | 77.747 |
| Shoulder pain | 45 | 0.036 | 77.784 |
| Cardiac disorder | 44 | 0.036 | 77.819 |
| Cardiovascular disorder | 44 | 0.036 | 77.855 |
| Diet refusal | 44 | 0.036 | 77.89 |
| Facial pain | 44 | 0.036 | 77.926 |
| Food intolerance | 44 | 0.036 | 77.962 |
| Jaundice | 44 | 0.036 | 77.997 |
| Menorrhagia | 44 | 0.036 | 78.033 |
| Middle insomnia | 44 | 0.036 | 78.069 |
| Mood swings | 44 | 0.036 | 78.104 |
| Ophthalmic herpes zoster | 44 | 0.036 | 78.14 |
| Pharyngolaryngeal pain | 44 | 0.036 | 78.176 |
| Restlessness | 44 | 0.036 | 78.211 |
| Sensation of heaviness | 44 | 0.036 | 78.247 |
| VIIth nerve paralysis | 44 | 0.036 | 78.282 |
| Cytogenetic analysis normal | 43 | 0.035 | 78.317 |
| Haemoglobin decreased | 43 | 0.035 | 78.352 |
| Haemoglobin normal | 43 | 0.035 | 78.387 |
| Injection site pruritus | 43 | 0.035 | 78.422 |
| Metabolic function test normal | 43 | 0.035 | 78.457 |
| Mood altered | 43 | 0.035 | 78.491 |
| Nuclear magnetic resonance imaging spinal | 43 | 0.035 | 78.526 |
| Personality change | 43 | 0.035 | 78.561 |
| Swelling face | 43 | 0.035 | 78.596 |
| Biopsy skin abnormal | 42 | 0.034 | 78.63 |
| Disturbance in social behaviour | 42 | 0.034 | 78.664 |
| Dry skin | 42 | 0.034 | 78.698 |
| Dysgeusia | 42 | 0.034 | 78.732 |
| Hepatitis | 42 | 0.034 | 78.766 |
| Petit mal epilepsy | 42 | 0.034 | 78.8 |
| Poor quality sleep | 42 | 0.034 | 78.834 |
| Sudden hearing loss | 42 | 0.034 | 78.868 |
| Angiopathy | 41 | 0.033 | 78.901 |
| Antibody test negative | 41 | 0.033 | 78.934 |
| Blood cholesterol increased | 41 | 0.033 | 78.968 |
| Blood creatine phosphokinase normal | 41 | 0.033 | 79.001 |
| Colitis | 41 | 0.033 | 79.034 |
| Communication disorder | 41 | 0.033 | 79.067 |
| Extensor plantar response | 41 | 0.033 | 79.1 |
| Ultrasound scan abnormal | 41 | 0.033 | 79.134 |
| Gastroenteritis | 40 | 0.032 | 79.166 |
| Liver function test abnormal | 40 | 0.032 | 79.198 |
| Medication error | 40 | 0.032 | 79.231 |
| Paraplegia | 40 | 0.032 | 79.263 |
| Red blood cell sedimentation rate normal | 40 | 0.032 | 79.296 |
| Carpal tunnel syndrome | 39 | 0.032 | 79.327 |
| Cystitis | 39 | 0.032 | 79.359 |
| Electrocardiogram abnormal | 39 | 0.032 | 79.39 |
| Growth retardation | 39 | 0.032 | 79.422 |
| Head banging | 39 | 0.032 | 79.454 |
| Incontinence | 39 | 0.032 | 79.485 |
| Rash pruritic | 39 | 0.032 | 79.517 |
| Rotator cuff syndrome | 39 | 0.032 | 79.548 |
| Serum sickness | 39 | 0.032 | 79.58 |
| Synovitis | 39 | 0.032 | 79.612 |
| Tilt table test normal | 39 | 0.032 | 79.643 |
| Urinary retention | 39 | 0.032 | 79.675 |
| Urine analysis abnormal | 39 | 0.032 | 79.706 |
| Blood alkaline phosphatase increased | 38 | 0.031 | 79.737 |
| Blood culture negative | 38 | 0.031 | 79.768 |
| Obsessive-compulsive disorder | 38 | 0.031 | 79.799 |
| Peroneal nerve palsy | 38 | 0.031 | 79.829 |
| Petechiae | 38 | 0.031 | 79.86 |
| Rash macular | 38 | 0.031 | 79.891 |
| Bacterial test negative | 37 | 0.03 | 79.921 |
| Blood calcium normal | 37 | 0.03 | 79.951 |
| Chest X-ray abnormal | 37 | 0.03 | 79.981 |
| CSF glucose normal | 37 | 0.03 | 80.011 |
| Dysaesthesia | 37 | 0.03 | 80.041 |
| Ear discomfort | 37 | 0.03 | 80.071 |
| Musculoskeletal chest pain | 37 | 0.03 | 80.101 |
| Pain in jaw | 37 | 0.03 | 80.131 |
| Panic attack | 37 | 0.03 | 80.161 |
| Tendon disorder | 37 | 0.03 | 80.191 |
| Thrombocytopenia | 37 | 0.03 | 80.221 |
| Vasodilatation | 37 | 0.03 | 80.251 |
| Abdominal pain lower | 36 | 0.029 | 80.28 |
| Biopsy | 36 | 0.029 | 80.309 |
| Blood product transfusion | 36 | 0.029 | 80.338 |
| Hepatic function abnormal | 36 | 0.029 | 80.367 |
| Psychomotor retardation | 36 | 0.029 | 80.396 |
| Respiratory failure | 36 | 0.029 | 80.426 |
| Autoimmune thyroiditis | 35 | 0.028 | 80.454 |
| Blood sodium normal | 35 | 0.028 | 80.482 |
| Cytogenetic analysis | 35 | 0.028 | 80.511 |
| Dysgraphia | 35 | 0.028 | 80.539 |
| Face oedema | 35 | 0.028 | 80.567 |
| Fungal infection | 35 | 0.028 | 80.596 |
| Gastritis | 35 | 0.028 | 80.624 |
| Raynaud’s phenomenon | 35 | 0.028 | 80.652 |
| Rheumatoid factor | 35 | 0.028 | 80.681 |
| Acoustic stimulation tests | 34 | 0.028 | 80.708 |
| Bradycardia | 34 | 0.028 | 80.736 |
| Cerebral haemorrhage | 34 | 0.028 | 80.763 |
| Cerebral infarction | 34 | 0.028 | 80.791 |
| Formication | 34 | 0.028 | 80.818 |
| Lacrimation increased | 34 | 0.028 | 80.846 |
| Polymyalgia rheumatica | 34 | 0.028 | 80.873 |
| Stress | 34 | 0.028 | 80.901 |
| Ageusia | 33 | 0.027 | 80.928 |
| Borrelia test | 33 | 0.027 | 80.954 |
| Developmental regression | 33 | 0.027 | 80.981 |
| Educational problem | 33 | 0.027 | 81.008 |
| Erectile dysfunction | 33 | 0.027 | 81.035 |
| Exposure during pregnancy | 33 | 0.027 | 81.061 |
| Facial paresis | 33 | 0.027 | 81.088 |
| Gastric disorder | 33 | 0.027 | 81.115 |
| Heart rate irregular | 33 | 0.027 | 81.142 |
| Hyperreflexia | 33 | 0.027 | 81.168 |
| Language disorder | 33 | 0.027 | 81.195 |
| Muscle tightness | 33 | 0.027 | 81.222 |
| Nuclear magnetic resonance imaging spinal normal | 33 | 0.027 | 81.248 |
| Ocular hyperaemia | 33 | 0.027 | 81.275 |
| Ophthalmological examination | 33 | 0.027 | 81.302 |
| Polyuria | 33 | 0.027 | 81.329 |
| Rheumatoid factor negative | 33 | 0.027 | 81.355 |
| Scar | 33 | 0.027 | 81.382 |
| X-ray limb normal | 33 | 0.027 | 81.409 |
| Adverse reaction | 32 | 0.026 | 81.435 |
| Aspartate aminotransferase normal | 32 | 0.026 | 81.461 |
| CSF oligoclonal band present | 32 | 0.026 | 81.487 |
| Respiratory arrest | 32 | 0.026 | 81.512 |
| Skin burning sensation | 32 | 0.026 | 81.538 |
| X-ray abnormal | 32 | 0.026 | 81.564 |
| Acoustic stimulation tests abnormal | 31 | 0.025 | 81.589 |
| Alanine aminotransferase normal | 31 | 0.025 | 81.615 |
| Blood potassium normal | 31 | 0.025 | 81.64 |
| Cerebellar ataxia | 31 | 0.025 | 81.665 |
| CSF culture negative | 31 | 0.025 | 81.69 |
| CSF test | 31 | 0.025 | 81.715 |
| Diagnostic procedure | 31 | 0.025 | 81.74 |
| Drooling | 31 | 0.025 | 81.765 |
| Emotional disorder | 31 | 0.025 | 81.79 |
| Gastrointestinal tube insertion | 31 | 0.025 | 81.815 |
| HIV test negative | 31 | 0.025 | 81.84 |
| Immunology test | 31 | 0.025 | 81.866 |
| Monoparesis | 31 | 0.025 | 81.891 |
| No reaction on previous exposure to drug | 31 | 0.025 | 81.916 |
| Pain of skin | 31 | 0.025 | 81.941 |
| Paraesthesia oral | 31 | 0.025 | 81.966 |
| Photosensitivity reaction | 31 | 0.025 | 81.991 |
| Respiratory tract congestion | 31 | 0.025 | 82.016 |
| Seizure like phenomena | 31 | 0.025 | 82.041 |
| Shock | 31 | 0.025 | 82.066 |
| Sleep study | 31 | 0.025 | 82.092 |
| Uveitis | 31 | 0.025 | 82.117 |
| Vestibular disorder | 31 | 0.025 | 82.142 |
| Adverse event | 30 | 0.024 | 82.166 |
| Affect lability | 30 | 0.024 | 82.19 |
| Angiogram | 30 | 0.024 | 82.215 |
| Apraxia | 30 | 0.024 | 82.239 |
| Blood creatinine increased | 30 | 0.024 | 82.263 |
| Blood pressure decreased | 30 | 0.024 | 82.288 |
| Blood urea normal | 30 | 0.024 | 82.312 |
| Cerebral palsy | 30 | 0.024 | 82.336 |
| Echocardiogram abnormal | 30 | 0.024 | 82.36 |
| Hyperkinesia | 30 | 0.024 | 82.385 |
| Immunoglobulins increased | 30 | 0.024 | 82.409 |
| Intervertebral disc protrusion | 30 | 0.024 | 82.433 |
| Listless | 30 | 0.024 | 82.458 |
| Micturition urgency | 30 | 0.024 | 82.482 |
| Muscle spasticity | 30 | 0.024 | 82.506 |
| Myocardial infarction | 30 | 0.024 | 82.531 |
| Nuchal rigidity | 30 | 0.024 | 82.555 |
| Opisthotonus | 30 | 0.024 | 82.579 |
| Renal failure | 30 | 0.024 | 82.603 |
| Tilt table test | 30 | 0.024 | 82.628 |
| Antibody test positive | 29 | 0.023 | 82.651 |
| C-reactive protein | 29 | 0.023 | 82.675 |
| Crohn’s disease | 29 | 0.023 | 82.698 |
| Decreased immune responsiveness | 29 | 0.023 | 82.722 |
| Dystonia | 29 | 0.023 | 82.745 |
| Immunology test normal | 29 | 0.023 | 82.769 |
| Infectious mononucleosis | 29 | 0.023 | 82.792 |
| Injection site cellulitis | 29 | 0.023 | 82.816 |
| Mental status changes | 29 | 0.023 | 82.839 |
| Mouth ulceration | 29 | 0.023 | 82.863 |
| Orthostatic hypotension | 29 | 0.023 | 82.886 |
| Psoriasis | 29 | 0.023 | 82.91 |
| Purpura | 29 | 0.023 | 82.933 |
| Audiogram abnormal | 28 | 0.023 | 82.956 |
| Blood bilirubin increased | 28 | 0.023 | 82.978 |
| Cyst | 28 | 0.023 | 83.001 |
| Cytomegalovirus test negative | 28 | 0.023 | 83.024 |
| Endoscopy | 28 | 0.023 | 83.046 |
| Magnetic resonance imaging | 28 | 0.023 | 83.069 |
| Muscle rigidity | 28 | 0.023 | 83.092 |
| Polydipsia | 28 | 0.023 | 83.115 |
| Tenosynovitis | 28 | 0.023 | 83.137 |
| Throat tightness | 28 | 0.023 | 83.16 |
| Urine analysis normal | 28 | 0.023 | 83.183 |
| Abnormal loss of weight | 27 | 0.022 | 83.204 |
| Altered state of consciousness | 27 | 0.022 | 83.226 |
| Blepharospasm | 27 | 0.022 | 83.248 |
| Blood alkaline phosphatase normal | 27 | 0.022 | 83.27 |
| Blood lactate dehydrogenase increased | 27 | 0.022 | 83.292 |
| Blood thyroid stimulating hormone | 27 | 0.022 | 83.314 |
| Blood urea increased | 27 | 0.022 | 83.336 |
| Cerebral ischaemia | 27 | 0.022 | 83.357 |
| Choking | 27 | 0.022 | 83.379 |
| Coeliac disease | 27 | 0.022 | 83.401 |
| Colitis ulcerative | 27 | 0.022 | 83.423 |
| Colonoscopy | 27 | 0.022 | 83.445 |
| CSF protein normal | 27 | 0.022 | 83.467 |
| CSF white blood cell count increased | 27 | 0.022 | 83.489 |
| Dermatitis | 27 | 0.022 | 83.511 |
| Epstein-Barr virus test negative | 27 | 0.022 | 83.532 |
| Gamma-glutamyltransferase increased | 27 | 0.022 | 83.554 |
| Mydriasis | 27 | 0.022 | 83.576 |
| Optic atrophy | 27 | 0.022 | 83.598 |
| Paralysis flaccid | 27 | 0.022 | 83.62 |
| Sleep apnoea syndrome | 27 | 0.022 | 83.642 |
| Spinal pain | 27 | 0.022 | 83.664 |
| Thyroid disorder | 27 | 0.022 | 83.686 |
| Thyroid function test normal | 27 | 0.022 | 83.707 |
| Tonsillitis | 27 | 0.022 | 83.729 |
| Urine mercury abnormal | 27 | 0.022 | 83.751 |
| Abscess | 26 | 0.021 | 83.772 |
| Atrial fibrillation | 26 | 0.021 | 83.793 |
| Fear | 26 | 0.021 | 83.814 |
| Flatulence | 26 | 0.021 | 83.835 |
| Hepatomegaly | 26 | 0.021 | 83.856 |
| Intentional self-injury | 26 | 0.021 | 83.877 |
| Intervertebral disc degeneration | 26 | 0.021 | 83.899 |
| Liver function test normal | 26 | 0.021 | 83.92 |
| Neoplasm | 26 | 0.021 | 83.941 |
| Polymerase chain reaction | 26 | 0.021 | 83.962 |
| Product administered at inappropriate site | 26 | 0.021 | 83.983 |
| Respiratory distress | 26 | 0.021 | 84.004 |
| Skin exfoliation | 26 | 0.021 | 84.025 |
| Status epilepticus | 26 | 0.021 | 84.046 |
| Temperature intolerance | 26 | 0.021 | 84.067 |
| Adverse drug reaction | 25 | 0.02 | 84.087 |
| Computerised tomogram head abnormal | 25 | 0.02 | 84.107 |
| Dermatitis bullous | 25 | 0.02 | 84.128 |
| Drug exposure during pregnancy | 25 | 0.02 | 84.148 |
| Feeling of body temperature change | 25 | 0.02 | 84.168 |
| Gluten sensitivity | 25 | 0.02 | 84.188 |
| Head injury | 25 | 0.02 | 84.209 |
| Hypercholesterolaemia | 25 | 0.02 | 84.229 |
| Hypoaesthesia oral | 25 | 0.02 | 84.249 |
| Infection susceptibility increased | 25 | 0.02 | 84.269 |
| Injection site nodule | 25 | 0.02 | 84.29 |
| Lactose intolerance | 25 | 0.02 | 84.31 |
| Learning disorder | 25 | 0.02 | 84.33 |
| Parosmia | 25 | 0.02 | 84.35 |
| Pelvic pain | 25 | 0.02 | 84.371 |
| Peripheral vascular disorder | 25 | 0.02 | 84.391 |
| Pharyngeal oedema | 25 | 0.02 | 84.411 |
| Productive cough | 25 | 0.02 | 84.431 |
| Salivary hypersecretion | 25 | 0.02 | 84.452 |
| Scan brain | 25 | 0.02 | 84.472 |
| Temperature regulation disorder | 25 | 0.02 | 84.492 |
| Thrombosis | 25 | 0.02 | 84.512 |
| Tracheostomy | 25 | 0.02 | 84.533 |
| X-ray limb abnormal | 25 | 0.02 | 84.553 |
| Allodynia | 24 | 0.019 | 84.572 |
| Bacterial test | 24 | 0.019 | 84.592 |
| Blood chloride normal | 24 | 0.019 | 84.611 |
| Blood immunoglobulin G normal | 24 | 0.019 | 84.631 |
| Blood thyroid stimulating hormone decreased | 24 | 0.019 | 84.65 |
| Body temperature fluctuation | 24 | 0.019 | 84.67 |
| Cardiac failure | 24 | 0.019 | 84.689 |
| Central nervous system inflammation | 24 | 0.019 | 84.708 |
| Dermatomyositis | 24 | 0.019 | 84.728 |
| Echocardiogram normal | 24 | 0.019 | 84.747 |
| Foetal disorder | 24 | 0.019 | 84.767 |
| Haematuria | 24 | 0.019 | 84.786 |
| Head discomfort | 24 | 0.019 | 84.806 |
| Incomplete course of vaccination | 24 | 0.019 | 84.825 |
| Induration | 24 | 0.019 | 84.845 |
| Leukopenia | 24 | 0.019 | 84.864 |
| Musculoskeletal discomfort | 24 | 0.019 | 84.883 |
| Optic neuritis retrobulbar | 24 | 0.019 | 84.903 |
| Renal impairment | 24 | 0.019 | 84.922 |
| Sleep study abnormal | 24 | 0.019 | 84.942 |
| Abdominal X-ray | 23 | 0.019 | 84.96 |
| Antineutrophil cytoplasmic antibody negative | 23 | 0.019 | 84.979 |
| Biopsy muscle | 23 | 0.019 | 84.998 |
| Bladder disorder | 23 | 0.019 | 85.016 |
| Blood immunoglobulin G | 23 | 0.019 | 85.035 |
| Borrelia burgdorferi serology negative | 23 | 0.019 | 85.053 |
| Congenital anomaly | 23 | 0.019 | 85.072 |
| Injection site abscess | 23 | 0.019 | 85.091 |
| Mass | 23 | 0.019 | 85.109 |
| Muscle fatigue | 23 | 0.019 | 85.128 |
| Ophthalmological examination abnormal | 23 | 0.019 | 85.147 |
| Partial seizures | 23 | 0.019 | 85.165 |
| Rheumatoid factor positive | 23 | 0.019 | 85.184 |
| Scan | 23 | 0.019 | 85.203 |
| Similar reaction on previous exposure to drug | 23 | 0.019 | 85.221 |
| Sneezing | 23 | 0.019 | 85.24 |
| Trigeminal neuralgia | 23 | 0.019 | 85.258 |
| Allergy test positive | 22 | 0.018 | 85.276 |
| Anaphylactic shock | 22 | 0.018 | 85.294 |
| Appendicectomy | 22 | 0.018 | 85.312 |
| Arthritis reactive | 22 | 0.018 | 85.33 |
| Blood albumin normal | 22 | 0.018 | 85.348 |
| Blood potassium decreased | 22 | 0.018 | 85.365 |
| Body temperature decreased | 22 | 0.018 | 85.383 |
| Bronchiolitis | 22 | 0.018 | 85.401 |
| Congenital central nervous system anomaly | 22 | 0.018 | 85.419 |
| Diarrhoea haemorrhagic | 22 | 0.018 | 85.437 |
| Eyelid oedema | 22 | 0.018 | 85.454 |
| Glycosylated haemoglobin increased | 22 | 0.018 | 85.472 |
| Haematocrit decreased | 22 | 0.018 | 85.49 |
| HLA marker study | 22 | 0.018 | 85.508 |
| Joint effusion | 22 | 0.018 | 85.526 |
| Learning disability | 22 | 0.018 | 85.544 |
| Lyme disease | 22 | 0.018 | 85.561 |
| Myoclonic epilepsy | 22 | 0.018 | 85.579 |
| Pleural effusion | 22 | 0.018 | 85.597 |
| Proteinuria | 22 | 0.018 | 85.615 |
| Acupuncture | 21 | 0.017 | 85.632 |
| Blindness transient | 21 | 0.017 | 85.649 |
| Breast pain | 21 | 0.017 | 85.666 |
| Eyelid function disorder | 21 | 0.017 | 85.683 |
| Groin pain | 21 | 0.017 | 85.7 |
| Henoch-Schonlein purpura | 21 | 0.017 | 85.717 |
| Hormone level abnormal | 21 | 0.017 | 85.734 |
| Hypophagia | 21 | 0.017 | 85.751 |
| Impaired gastric emptying | 21 | 0.017 | 85.768 |
| Injection site discomfort | 21 | 0.017 | 85.785 |
| Intellectual disability | 21 | 0.017 | 85.802 |
| Loss of control of legs | 21 | 0.017 | 85.819 |
| Neurogenic bladder | 21 | 0.017 | 85.836 |
| Ovarian cyst | 21 | 0.017 | 85.853 |
| Pericarditis | 21 | 0.017 | 85.87 |
| Thyroiditis | 21 | 0.017 | 85.887 |
| Urinary tract disorder | 21 | 0.017 | 85.904 |
| Viral test negative | 21 | 0.017 | 85.921 |
| Vitamin D decreased | 21 | 0.017 | 85.938 |
| X-ray limb | 21 | 0.017 | 85.955 |
| Abnormal faeces | 20 | 0.016 | 85.971 |
| Acoustic stimulation tests normal | 20 | 0.016 | 85.987 |
| Asterixis | 20 | 0.016 | 86.004 |
| Bladder catheterisation | 20 | 0.016 | 86.02 |
| Blood culture | 20 | 0.016 | 86.036 |
| Blood glucose decreased | 20 | 0.016 | 86.052 |
| Blood immunoglobulin M | 20 | 0.016 | 86.068 |
| Cerebral atrophy | 20 | 0.016 | 86.085 |
| Chromaturia | 20 | 0.016 | 86.101 |
| Eosinophilia | 20 | 0.016 | 86.117 |
| Extrapyramidal disorder | 20 | 0.016 | 86.133 |
| Eye irritation | 20 | 0.016 | 86.149 |
| Functional gastrointestinal disorder | 20 | 0.016 | 86.166 |
| Imaging procedure | 20 | 0.016 | 86.182 |
| Immobile | 20 | 0.016 | 86.198 |
| Lip swelling | 20 | 0.016 | 86.214 |
| Lower respiratory tract infection | 20 | 0.016 | 86.23 |
| Myasthenia gravis | 20 | 0.016 | 86.247 |
| Nephrotic syndrome | 20 | 0.016 | 86.263 |
| Nodule | 20 | 0.016 | 86.279 |
| Psychomotor skills impaired | 20 | 0.016 | 86.295 |
| Stomatitis | 20 | 0.016 | 86.311 |
| Swollen tongue | 20 | 0.016 | 86.328 |
| Varicella | 20 | 0.016 | 86.344 |
| White blood cell count decreased | 20 | 0.016 | 86.36 |
| Affective disorder | 19 | 0.015 | 86.375 |
| Allergy test negative | 19 | 0.015 | 86.391 |
| Blood albumin decreased | 19 | 0.015 | 86.406 |
| Blood bilirubin normal | 19 | 0.015 | 86.421 |
| Blood folate normal | 19 | 0.015 | 86.437 |
| Blood heavy metal increased | 19 | 0.015 | 86.452 |
| Blood iron decreased | 19 | 0.015 | 86.468 |
| Blood sodium decreased | 19 | 0.015 | 86.483 |
| Blood urine present | 19 | 0.015 | 86.498 |
| Cardiomyopathy | 19 | 0.015 | 86.514 |
| Cerebral disorder | 19 | 0.015 | 86.529 |
| Coagulopathy | 19 | 0.015 | 86.545 |
| Conversion disorder | 19 | 0.015 | 86.56 |
| Cytomegalovirus test positive | 19 | 0.015 | 86.575 |
| Deafness bilateral | 19 | 0.015 | 86.591 |
| Demyelinating polyneuropathy | 19 | 0.015 | 86.606 |
| DNA antibody negative | 19 | 0.015 | 86.622 |
| Drug hypersensitivity | 19 | 0.015 | 86.637 |
| Electrocardiogram ambulatory | 19 | 0.015 | 86.652 |
| Gene mutation identification test | 19 | 0.015 | 86.668 |
| Haematoma | 19 | 0.015 | 86.683 |
| Hydrocephalus | 19 | 0.015 | 86.698 |
| Hypermobility syndrome | 19 | 0.015 | 86.714 |
| Incorrect dose administered | 19 | 0.015 | 86.729 |
| Juvenile idiopathic arthritis | 19 | 0.015 | 86.745 |
| Liver disorder | 19 | 0.015 | 86.76 |
| Milk allergy | 19 | 0.015 | 86.775 |
| Plethysmography | 19 | 0.015 | 86.791 |
| Premature menopause | 19 | 0.015 | 86.806 |
| Psychotic disorder | 19 | 0.015 | 86.822 |
| Restless legs syndrome | 19 | 0.015 | 86.837 |
| Resuscitation | 19 | 0.015 | 86.852 |
| Sensory processing disorder | 19 | 0.015 | 86.868 |
| Sjogren’s syndrome | 19 | 0.015 | 86.883 |
| Vomiting projectile | 19 | 0.015 | 86.899 |
| Audiogram | 18 | 0.015 | 86.913 |
| Basophil count normal | 18 | 0.015 | 86.928 |
| Blood glucose | 18 | 0.015 | 86.942 |
| Blood mercury abnormal | 18 | 0.015 | 86.957 |
| Brachial plexopathy | 18 | 0.015 | 86.971 |
| Cardiac stress test | 18 | 0.015 | 86.986 |
| Chronic obstructive pulmonary disease | 18 | 0.015 | 87.001 |
| Complement factor C3 | 18 | 0.015 | 87.015 |
| CSF white blood cell count negative | 18 | 0.015 | 87.03 |
| Culture urine negative | 18 | 0.015 | 87.044 |
| Dermatitis atopic | 18 | 0.015 | 87.059 |
| Ear tube insertion | 18 | 0.015 | 87.073 |
| Faeces discoloured | 18 | 0.015 | 87.088 |
| Flank pain | 18 | 0.015 | 87.103 |
| Hepatic enzyme increased | 18 | 0.015 | 87.117 |
| Hyponatraemia | 18 | 0.015 | 87.132 |
| Hyporesponsive to stimuli | 18 | 0.015 | 87.146 |
| Immune thrombocytopenic purpura | 18 | 0.015 | 87.161 |
| Limb injury | 18 | 0.015 | 87.176 |
| Nuclear magnetic resonance imaging spinal cord abnormal | 18 | 0.015 | 87.19 |
| Paraparesis | 18 | 0.015 | 87.205 |
| Pulmonary oedema | 18 | 0.015 | 87.219 |
| Rash papular | 18 | 0.015 | 87.234 |
| Skin nodule | 18 | 0.015 | 87.248 |
| Streptococcus test positive | 18 | 0.015 | 87.263 |
| Throat irritation | 18 | 0.015 | 87.278 |
| Toe walking | 18 | 0.015 | 87.292 |
| Torticollis | 18 | 0.015 | 87.307 |
| Vaccination site swelling | 18 | 0.015 | 87.321 |
| Vitamin D deficiency | 18 | 0.015 | 87.336 |
| Weight gain poor | 18 | 0.015 | 87.35 |
| Antibody test | 17 | 0.014 | 87.364 |
| Atelectasis | 17 | 0.014 | 87.378 |
| Biopsy muscle normal | 17 | 0.014 | 87.392 |
| Cardiac failure congestive | 17 | 0.014 | 87.406 |
| Complement factor C4 | 17 | 0.014 | 87.419 |
| Dysphemia | 17 | 0.014 | 87.433 |
| Ecchymosis | 17 | 0.014 | 87.447 |
| Erythema multiforme | 17 | 0.014 | 87.461 |
| Extensive swelling of vaccinated limb | 17 | 0.014 | 87.474 |
| Fluid retention | 17 | 0.014 | 87.488 |
| High-pitched crying | 17 | 0.014 | 87.502 |
| Hypoaesthesia facial | 17 | 0.014 | 87.516 |
| Hypotonic-hyporesponsive episode | 17 | 0.014 | 87.529 |
| Injection site discolouration | 17 | 0.014 | 87.543 |
| Intracranial pressure increased | 17 | 0.014 | 87.557 |
| Malabsorption | 17 | 0.014 | 87.571 |
| Motor developmental delay | 17 | 0.014 | 87.585 |
| Nightmare | 17 | 0.014 | 87.598 |
| Ophthalmoplegia | 17 | 0.014 | 87.612 |
| Platelet count increased | 17 | 0.014 | 87.626 |
| Pruritus generalised | 17 | 0.014 | 87.64 |
| Sciatica | 17 | 0.014 | 87.653 |
| Ultrasound Doppler | 17 | 0.014 | 87.667 |
| Anal incontinence | 16 | 0.013 | 87.68 |
| Anosmia | 16 | 0.013 | 87.693 |
| Antinuclear antibody increased | 16 | 0.013 | 87.706 |
| Aphonia | 16 | 0.013 | 87.719 |
| Bed rest | 16 | 0.013 | 87.732 |
| Blood immunoglobulin G decreased | 16 | 0.013 | 87.745 |
| Blood pressure fluctuation | 16 | 0.013 | 87.758 |
| Body temperature | 16 | 0.013 | 87.771 |
| Borrelia test positive | 16 | 0.013 | 87.784 |
| Brain stem auditory evoked response normal | 16 | 0.013 | 87.797 |
| Cardiolipin antibody negative | 16 | 0.013 | 87.81 |
| Cerebrovascular disorder | 16 | 0.013 | 87.823 |
| Colonoscopy abnormal | 16 | 0.013 | 87.836 |
| Corrective lens user | 16 | 0.013 | 87.849 |
| Culture negative | 16 | 0.013 | 87.862 |
| Drug administered to patient of inappropriate age | 16 | 0.013 | 87.874 |
| Drug withdrawal syndrome | 16 | 0.013 | 87.887 |
| Enuresis | 16 | 0.013 | 87.9 |
| Epstein-Barr virus infection | 16 | 0.013 | 87.913 |
| Eye discharge | 16 | 0.013 | 87.926 |
| Failure to thrive | 16 | 0.013 | 87.939 |
| Gene mutation identification test positive | 16 | 0.013 | 87.952 |
| Haematocrit normal | 16 | 0.013 | 87.965 |
| Heart rate decreased | 16 | 0.013 | 87.978 |
| Hepatocellular damage | 16 | 0.013 | 87.991 |
| Herpes simplex | 16 | 0.013 | 88.004 |
| Hypokalaemia | 16 | 0.013 | 88.017 |
| Increased tendency to bruise | 16 | 0.013 | 88.03 |
| Injection site atrophy | 16 | 0.013 | 88.043 |
| Injection site bruising | 16 | 0.013 | 88.056 |
| Injection site movement impairment | 16 | 0.013 | 88.069 |
| Joint crepitation | 16 | 0.013 | 88.082 |
| Laryngitis | 16 | 0.013 | 88.095 |
| Lymph node pain | 16 | 0.013 | 88.108 |
| Lymphocytosis | 16 | 0.013 | 88.121 |
| Meningism | 16 | 0.013 | 88.134 |
| Meningitis pneumococcal | 16 | 0.013 | 88.147 |
| Myelopathy | 16 | 0.013 | 88.16 |
| Nerve conduction studies normal | 16 | 0.013 | 88.173 |
| Oxygen saturation decreased | 16 | 0.013 | 88.186 |
| Papilloedema | 16 | 0.013 | 88.198 |
| Retinal detachment | 16 | 0.013 | 88.211 |
| Scan with contrast | 16 | 0.013 | 88.224 |
| Schellong test | 16 | 0.013 | 88.237 |
| Sensory integrative dysfunction | 16 | 0.013 | 88.25 |
| Stool analysis | 16 | 0.013 | 88.263 |
| Transient ischaemic attack | 16 | 0.013 | 88.276 |
| Ultrasound abdomen normal | 16 | 0.013 | 88.289 |
| Varicella post vaccine | 16 | 0.013 | 88.302 |
| Visual evoked potentials abnormal | 16 | 0.013 | 88.315 |
| White blood cell count normal | 16 | 0.013 | 88.328 |
| Abnormal dreams | 15 | 0.012 | 88.34 |
| Abortion spontaneous | 15 | 0.012 | 88.352 |
| Allergy to vaccine | 15 | 0.012 | 88.365 |
| Anti-cyclic citrullinated peptide antibody negative | 15 | 0.012 | 88.377 |
| Aphagia | 15 | 0.012 | 88.389 |
| Apparent life threatening event | 15 | 0.012 | 88.401 |
| Blood aluminium increased | 15 | 0.012 | 88.413 |
| Blood calcium decreased | 15 | 0.012 | 88.425 |
| Blood count normal | 15 | 0.012 | 88.437 |
| Blood heavy metal test | 15 | 0.012 | 88.45 |
| Blood immunoglobulin E increased | 15 | 0.012 | 88.462 |
| Chemotherapy | 15 | 0.012 | 88.474 |
| Coagulation test normal | 15 | 0.012 | 88.486 |
| Computerised tomogram abdomen | 15 | 0.012 | 88.498 |
| Computerised tomogram thorax abnormal | 15 | 0.012 | 88.51 |
| CSF oligoclonal band absent | 15 | 0.012 | 88.522 |
| Differential white blood cell count | 15 | 0.012 | 88.535 |
| DNA test for fragile X | 15 | 0.012 | 88.547 |
| Feeding disorder of infancy or early childhood | 15 | 0.012 | 88.559 |
| Fungal test | 15 | 0.012 | 88.571 |
| Gastrostomy | 15 | 0.012 | 88.583 |
| Glomerulonephritis | 15 | 0.012 | 88.595 |
| Hyperthermia | 15 | 0.012 | 88.607 |
| Hypoglycaemia | 15 | 0.012 | 88.62 |
| Injection site haematoma | 15 | 0.012 | 88.632 |
| Injection site joint pain | 15 | 0.012 | 88.644 |
| Injection site vesicles | 15 | 0.012 | 88.656 |
| Joint injury | 15 | 0.012 | 88.668 |
| Kawasaki’s disease | 15 | 0.012 | 88.68 |
| Micturition disorder | 15 | 0.012 | 88.693 |
| Mucous stools | 15 | 0.012 | 88.705 |
| Necrosis | 15 | 0.012 | 88.717 |
| Panic reaction | 15 | 0.012 | 88.729 |
| Peripheral sensory neuropathy | 15 | 0.012 | 88.741 |
| Photopsia | 15 | 0.012 | 88.753 |
| Physiotherapy | 15 | 0.012 | 88.765 |
| Post vaccination syndrome | 15 | 0.012 | 88.778 |
| Quadriparesis | 15 | 0.012 | 88.79 |
| Rash pustular | 15 | 0.012 | 88.802 |
| Red blood cell sedimentation rate | 15 | 0.012 | 88.814 |
| Renal failure acute | 15 | 0.012 | 88.826 |
| Scotoma | 15 | 0.012 | 88.838 |
| Skin striae | 15 | 0.012 | 88.85 |
| Thrombocythaemia | 15 | 0.012 | 88.863 |
| Transfusion | 15 | 0.012 | 88.875 |
| Wrong drug administered | 15 | 0.012 | 88.887 |
| Amyotrophic lateral sclerosis | 14 | 0.011 | 88.898 |
| Angina pectoris | 14 | 0.011 | 88.91 |
| Angioneurotic oedema | 14 | 0.011 | 88.921 |
| Appetite disorder | 14 | 0.011 | 88.932 |
| Atrophy | 14 | 0.011 | 88.944 |
| Biopsy skin | 14 | 0.011 | 88.955 |
| Blood immunoglobulin A | 14 | 0.011 | 88.966 |
| Blood lactate dehydrogenase normal | 14 | 0.011 | 88.978 |
| Bone scan | 14 | 0.011 | 88.989 |
| Brain scan abnormal | 14 | 0.011 | 89 |
| Candidiasis | 14 | 0.011 | 89.012 |
| Cataract | 14 | 0.011 | 89.023 |
| Computerised tomogram thorax | 14 | 0.011 | 89.034 |
| Cow’s milk intolerance | 14 | 0.011 | 89.046 |
| Decreased interest | 14 | 0.011 | 89.057 |
| Deep vein thrombosis | 14 | 0.011 | 89.068 |
| Epstein-Barr virus antibody positive | 14 | 0.011 | 89.08 |
| Eye pruritus | 14 | 0.011 | 89.091 |
| Food aversion | 14 | 0.011 | 89.102 |
| Foot deformity | 14 | 0.011 | 89.114 |
| Frequent bowel movements | 14 | 0.011 | 89.125 |
| Herpes zoster oticus | 14 | 0.011 | 89.136 |
| HLA marker study positive | 14 | 0.011 | 89.148 |
| Idiopathic thrombocytopenic purpura | 14 | 0.011 | 89.159 |
| Ill-defined disorder | 14 | 0.011 | 89.17 |
| Labyrinthitis | 14 | 0.011 | 89.182 |
| Lymphocyte count increased | 14 | 0.011 | 89.193 |
| Mental retardation | 14 | 0.011 | 89.204 |
| Mononucleosis heterophile test negative | 14 | 0.011 | 89.216 |
| Muscle swelling | 14 | 0.011 | 89.227 |
| Osteoporosis | 14 | 0.011 | 89.238 |
| Psoriatic arthropathy | 14 | 0.011 | 89.25 |
| Retinal disorder | 14 | 0.011 | 89.261 |
| Scab | 14 | 0.011 | 89.272 |
| Sexual dysfunction | 14 | 0.011 | 89.284 |
| Splenomegaly | 14 | 0.011 | 89.295 |
| Thrombocytopenic purpura | 14 | 0.011 | 89.306 |
| Angiotensin converting enzyme | 13 | 0.011 | 89.317 |
| Anti-cyclic citrullinated peptide antibody positive | 13 | 0.011 | 89.328 |
| Anti-thyroid antibody | 13 | 0.011 | 89.338 |
| Anti-thyroid antibody negative | 13 | 0.011 | 89.349 |
| Anxiety disorder | 13 | 0.011 | 89.359 |
| Blood chloride increased | 13 | 0.011 | 89.37 |
| Brain scan normal | 13 | 0.011 | 89.38 |
| Cardiomegaly | 13 | 0.011 | 89.391 |
| Concussion | 13 | 0.011 | 89.401 |
| CSF cell count increased | 13 | 0.011 | 89.412 |
| CSF cell count normal | 13 | 0.011 | 89.422 |
| CSF protein | 13 | 0.011 | 89.433 |
| Culture stool negative | 13 | 0.011 | 89.443 |
| Deafness permanent | 13 | 0.011 | 89.454 |
| Dyspnoea exertional | 13 | 0.011 | 89.464 |
| Encephalomyelitis | 13 | 0.011 | 89.475 |
| Endoscopy abnormal | 13 | 0.011 | 89.485 |
| Endoscopy upper gastrointestinal tract | 13 | 0.011 | 89.496 |
| Enema administration | 13 | 0.011 | 89.507 |
| Erythema nodosum | 13 | 0.011 | 89.517 |
| Eye inflammation | 13 | 0.011 | 89.528 |
| Full blood count abnormal | 13 | 0.011 | 89.538 |
| Furuncle | 13 | 0.011 | 89.549 |
| Gastrointestinal motility disorder | 13 | 0.011 | 89.559 |
| Gastrointestinal pain | 13 | 0.011 | 89.57 |
| Glossodynia | 13 | 0.011 | 89.58 |
| Haematology test normal | 13 | 0.011 | 89.591 |
| Hearing aid user | 13 | 0.011 | 89.601 |
| Hyperbilirubinaemia | 13 | 0.011 | 89.612 |
| Hyperlipidaemia | 13 | 0.011 | 89.622 |
| Impaired healing | 13 | 0.011 | 89.633 |
| Injection site hypoaesthesia | 13 | 0.011 | 89.643 |
| Intestinal obstruction | 13 | 0.011 | 89.654 |
| Investigation | 13 | 0.011 | 89.664 |
| Joint injection | 13 | 0.011 | 89.675 |
| Ketoacidosis | 13 | 0.011 | 89.686 |
| Livedo reticularis | 13 | 0.011 | 89.696 |
| Mastication disorder | 13 | 0.011 | 89.707 |
| Ophthalmological examination normal | 13 | 0.011 | 89.717 |
| Paranoia | 13 | 0.011 | 89.728 |
| Pericardial effusion | 13 | 0.011 | 89.738 |
| Protein urine present | 13 | 0.011 | 89.749 |
| Pupillary disorder | 13 | 0.011 | 89.759 |
| Radiculopathy | 13 | 0.011 | 89.77 |
| Rash morbilliform | 13 | 0.011 | 89.78 |
| Renal disorder | 13 | 0.011 | 89.791 |
| Retching | 13 | 0.011 | 89.801 |
| Retinal haemorrhage | 13 | 0.011 | 89.812 |
| Rhabdomyolysis | 13 | 0.011 | 89.822 |
| Sarcoidosis | 13 | 0.011 | 89.833 |
| Seasonal allergy | 13 | 0.011 | 89.843 |
| Secondary transmission | 13 | 0.011 | 89.854 |
| Secretion discharge | 13 | 0.011 | 89.864 |
| Ultrasound abdomen abnormal | 13 | 0.011 | 89.875 |
| Urine ketone body present | 13 | 0.011 | 89.886 |
| Acidosis | 12 | 0.01 | 89.895 |
| Anaphylactoid reaction | 12 | 0.01 | 89.905 |
| Angiogram normal | 12 | 0.01 | 89.915 |
| Antiphospholipid antibodies negative | 12 | 0.01 | 89.924 |
| Anti-thyroid antibody positive | 12 | 0.01 | 89.934 |
| Aplastic anaemia | 12 | 0.01 | 89.944 |
| Autopsy | 12 | 0.01 | 89.954 |
| Axillary pain | 12 | 0.01 | 89.963 |
| Biopsy bone marrow | 12 | 0.01 | 89.973 |
| Blood culture positive | 12 | 0.01 | 89.983 |
| Blood glucose abnormal | 12 | 0.01 | 89.992 |
| Blood immunoglobulin M normal | 12 | 0.01 | 90.002 |
| Blood iron normal | 12 | 0.01 | 90.012 |
| … | |||
| Wound drainage | 1 | 0.001 | 99.993 |
| Wrist fracture | 1 | 0.001 | 99.994 |
| Wrist surgery | 1 | 0.001 | 99.994 |
| Xanthopsia | 1 | 0.001 | 99.995 |
| Xeroderma | 1 | 0.001 | 99.996 |
| X-ray dental abnormal | 1 | 0.001 | 99.997 |
| X-ray of pelvis and hip abnormal | 1 | 0.001 | 99.998 |
| X-ray therapy to joint | 1 | 0.001 | 99.998 |
| X-ray with contrast lower gastrointestinal tract | 1 | 0.001 | 99.999 |
| Yersinia test negative | 1 | 0.001 | 100 |
| Total | 123,467 | 100 | |
| Rows | 5292 |
—
5292 rows
Edited to 1120 rows for readability.
—
Analysis:
n=123,467
As found in Counts of Each Symptom
Pyrexia (fever) is ranked in 1st place
The top nine symptoms, each accounting for 1% or more of all symptoms, are:
Pyrexia (fever), Pain, Fatigue, Headache, Arthralgia (joint pain), Asthenia (weakness), Myalgia (muscle pain), Pain in extremity, Dizziness
—
Autism is ranked in the 16th place, with 873 counts.
There is also:
Autism spectrum disorder is ranked 83rd, with 278 counts.
If these two results were combined, autism would have 1151 counts.
This would count for .932% (just less than 1%) of all 123,467 symptoms found, ranking autism in 12th place.
—
Of the 5292 unique spellings of symptoms listed,
10% of all symptoms, are counted in the top 6 symptoms.
20% of all symptoms, are counted in the top 17 symptoms.
30% of all symptoms, are counted in the top 36 symptoms.
80% of all symptoms, are counted in the top 527 symptoms.
90% of all symptoms, are counted in the top 1107 symptoms.
The final 10% are distributed over the remaining 4185 rows.
Another long tail.
—
Download:
For researchers who would like to see all 5292 rows, a zipped csv file can be downloaded here:
Symptoms_of_Disabled.zip, 57 kb
—